Investing News Moderna Stock Declines Amidst Concerns Over RSV Vaccine Efficacy Drop February 9, 2024
Investing News Moderna Stock Falls as Flu Vaccine Misses Early Success Criteria; Study Continues April 11, 2023
Investing News Moderna Stock Fell After CEO Bancel Told Lawmakers COVID Vaccination Price Rises Are Justified March 22, 2023
Investing News Moderna Stock Gains on Positive Data From the Phase III RSV Jab Study January 18, 2023
Investing News Moderna Stock Surged as It Expects COVID Vaccine Sales of $5 Billion in 2023, Down From $18 Billion in 2022 January 9, 2023
Investing News The Moderna Stock Is Gaining: The Cancer Vaccine Developed by Moderna Lowers the Death Rate Among Melanoma Patients December 15, 2022